Cover Image

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants

Show other versions (2)

Objective: Urinary tract infection (UTI) caused by resistant strains of bacteria is increasingly prevalent in children. The aim of this study was to investigate the clinical characteristics and risk factors for UTI caused by community-acquired extended-spectrum β-lactamase (CA-ESBL)-producing bacter...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yun Hee Kim (Author), Eun Mi Yang (Author), Chan Jong Kim (Author)
Format:	Book
Published:	Elsevier, 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urinary tract infection caused by community‐acquired extended‐spectrum β‐lactamase‐producing bacteria in infants
by: Yun Hee Kim, et al.
Published: (2017)

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants
by: Yun Hee Kim, et al.

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals
by: Chien-Hao Tseng, et al.
Published: (2023)

Clinical Significance of Extended-spectrum β-lactamase-producing Bacteria in First Pediatric Febrile Urinary Tract Infections and Differences between Age Groups
by: Sun Yeong Park, et al.
Published: (2017)

Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli
by: Kyo Jin Jo, et al.
Published: (2021)

Clinical Outcomes of Non-carbapenem Treatment for Urinary Tract Infections Caused by Extended-spectrum β-lactamase-producing
by: Eunae Kim, et al.
Published: (2021)

Isolation and molecular identification of extended spectrum beta-lactamase producing bacteria from urinary tract infection
by: Govindan Ramachandran, et al.
Published: (2021)

Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital
by: Rasool Soltani, et al.
Published: (2014)

Risk factor for urinary tract infections caused by Gram-negative Escherichia coli extended spectrum ß lactamase-producing bacteria
by: Ahmad Abdullah Majrashi, et al.
Published: (2020)

In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria
by: Patrik Mlynarcik, et al.
Published: (2021)

Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon
by: Karyom Djim-, et al.
Published: (2023)

Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae
by: Nadeem Sajjad Raja
Published: (2019)

β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates
by: Gopal Nandlal Agrawal, et al.
Published: (2017)

The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection
by: Xin-Tian He, et al.
Published: (2024)

Chemical composition and antibacterial activity of Origanum ramonense essential oil on the β-lactamase and extended- spectrum β-lactamase urinary tract isolates
by: Haitham N. Qaralleh
Published: (2018)

Characterization of Extended-Spectrum β-Lactamase-Producing and AmpC β-Lactamase-Producing <i>Enterobacterales</i> Isolated from Companion Animals in Korea
by: Se Ra Shin, et al.
Published: (2021)

Prevalence of extended spectrum beta-lactamase producing anaerobic bacteria in chronic periodontitis
by: Kirtilaxmi Kenchappa Benachinmardi, et al.
Published: (2014)

Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates
by: Rachel Burgoon, et al.
Published: (2023)

Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?
by: Ji Young Park
Published: (2021)

Risk factors for extended-spectrum b-lactamases-producing Escherichia coli urinary tract infections in a tertiary hospital
by: María Dolores Alcántar-Curiel, et al.
Published: (2015)

Heavy Metal (Arsenic) Induced Antibiotic Resistance among Extended-Spectrum β-Lactamase (ESBL) Producing Bacteria of Nosocomial Origin
by: Naveed Ahmed, et al.
Published: (2022)

Bloodstream Infections by Extended-spectrum β-lactamase-producing Klebsiella Species in Children
by: Aysun Yahşi, et al.
Published: (2023)

Analyses of Extended-Spectrum-β-Lactamase, Metallo-β-Lactamase, and AmpC-β-Lactamase Producing Enterobacteriaceae from the Dairy Value Chain in India
by: Tushar Kumar Dey, et al.
Published: (2023)

Bacteria Producing Extended Spectrum β-lactamases (ESBLs) in Hospitalized Patients: Prevalence, Antimicrobial Resistance Pattern and its Main Determinants
by: Mehdi Yousefipour, et al.
Published: (2019)

Perceptions of Carriership of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Bacteria: A Qualitative Study
by: Karin Uggla, et al.
Published: (2024)

Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women
by: Nguyen Thanh Viet, et al.
Published: (2021)

Urinary Tract Infections among Febrile Infants in Qatar: Extended-Spectrum-Beta-Lactamase (ESBL)-Producing Versus Non-ESBL Organisms
by: Mohammad Qusad, et al.
Published: (2024)

PEDIATRIC URINARY INFECTIONS, CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE - PRODUCING MICROORGANISMS IN VARNA, BULGARIA
by: Neli M. Ermenlieva, et al.
Published: (2016)

Effectiveness of Fosfomycin against Extended Spectrum Beta-Lactamase Producing Escherichia coli in Urinary Cultures
by: Hareem Gohar et al, et al.
Published: (2024)

Prevalence and Risk Factors of β-Lactamase Genes of Extended-Spectrum β-Lactamases-Producing From Dairy Farm Environments of Haryana, India
by: Sarin Kamboj, et al.
Published: (2024)

Extended-spectrum β-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan
by: Sayida A. Al-Jamei, et al.
Published: (2019)

Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli
by: Ubaid Rasool, et al.
Published: (2018)

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
by: Allison M. Gibble, et al.
Published: (2015)

Prevalence and Characterization of Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Isolated from Dogs and Cats in South Korea
by: Ji-Hyun Choi, et al.
Published: (2023)

Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> and Extended-Spectrum β-Lactamase-Producing <i>Klebsiella pneumoniae</i>
by: Elena Sendra, et al.
Published: (2022)

Prevalence and Molecular Epidemiology of Extended-Spectrum-β-Lactamase (ESBL)-Producing <i>Escherichia coli</i> from Multiple Sectors of Poultry Industry in Korea
by: Hyunsoo Kim, et al.
Published: (2021)

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain
by: Khalid Mubarak Bindayna, et al.
Published: (2009)

Ertapenem susceptibility of extended spectrum <it>beta</it>-lactamase-producing organisms
by: Selby Edward B, et al.
Published: (2007)

Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by: Luiza Arcas Gonçalves, et al.
Published: (2024)

Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal
by: Raju Shrestha, et al.
Published: (2019)